Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Pharmaceutical Supply – Medroxyprogesterone Acetate Injectable Suspension

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the supply and delivery of two units of Medroxyprogesterone Acetate Injectable Suspension identified by NSN 6505015295618, with full compliance required to federal and Department of Defense pharmaceutical standards. This subcontract, issued under the NAICS code 424210 for Pharmaceutical and Biological Product Merchant Wholesalers, is managed by the Defense Logistics Agency within the Department of Defense. The posting date is July 16, 2026, indicating the solicitation is anticipated for future award. The place of performance and specific delivery location are not detailed in the provided data, and no point of contact information is listed. The contract award details can be referenced through the official DIBBS link provided, which contains the full award record and transactional information.

General Info

Supply of two Medroxyprogesterone Acetate units per DLA requirements, compliant with DoD pharmaceutical standards.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of SPE2D226F3037.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

MEDROXYPROGESTERONE ACETATE INJECTABLE S

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply and delivery of 2 units of Medroxyprogesterone Acetate Injectable Suspension (NSN: 6505015295618) compliant with federal and DoD pharmaceutical standards.

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
SLED
FY26-OCME-RFQ-Primary Drug Standards-Open Market
Solicitation # Doc842986
The District of Columbia Office of Contracting and Procurement, on behalf of the Office of the Chief Medical Examiner (OCME), is soliciting bids for specialized National Institute of Standards and Technology (NIST) traceable primary drug standards for the OCME Forensic Toxicology Laboratory. This open market solicitation, identified as Doc842986, requires responses by August 24, 2026, with all inquiries submitted via the message board by August 20, 2026. The procurement falls under NAICS code 424210 and is managed by Contract Specialist Tiffany Starks and Contracting Officer Charlyn Moore. The contract mandates strict adherence to quality and compliance standards, requiring supplies to be new, of the best quality, and free from defects. Key administrative requirements include the submission of a Form W-9 and a PASS Master Supplier Form for vendor registration. For contracts exceeding 250,000 dollars, a notarized subcontracting plan is required, targeting a minimum of 35 percent of the contract value to certified Small Business Enterprises. Additionally, contractors must comply with the Living Wage Act for contracts over 100,000 dollars per year and adhere to the 51 percent District Residents New Hires requirement to receive final payment. Logistically, the District reserves the right to inspect supplies at both the origin and destination to ensure conformity. All packaging must be clearly marked with the contractor's name, contract number, and delivery address. While the specific period of performance and total contract value are not detailed in the provided documentation, the agreement is subject to standard District of Columbia government provisions, including the Buy American Act, ADA compliance, and specific clauses regarding the administrative resolution of claims.
Chief Medical Examiner (OCME)

POSTED

3 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency